|
|
|
Volumn 33, Issue 4, 1997, Pages 280-284
|
|
Copolymer 1 from the laboratory to FDA
a
|
|
Author keywords
Autoimmunity; Cop 1; Copaxone ; Experimental allergic encephalomyelitis; Multiple sclerosis
|
|
Indexed keywords
ALLERGIES;
ANTIGENS;
COPOLYMERS;
DISEASES;
DRUG THERAPY;
MEDICINE;
POLYPEPTIDES;
AUTOIMMUNITY;
ENCEPHALOMYELITIS;
MULTIPLE SCLEROSIS;
IMMUNOLOGY;
GLATIRAMER;
ALLERGIC ENCEPHALOMYELITIS;
ARTICLE;
AUTOIMMUNITY;
MULTIPLE SCLEROSIS;
SUPPRESSOR CELL;
T LYMPHOCYTE;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
AUTOIMMUNE DISEASES;
CLINICAL TRIALS;
CROSS REACTIONS;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISRAEL;
LABORATORIES;
MULTIPLE SCLEROSIS;
PEPTIDES;
POLYMERS;
T-LYMPHOCYTES;
T-LYMPHOCYTES, REGULATORY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0031126193
PISSN: 00212180
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (21)
|
|
References (21)
|
